ABSTRACT
OBJECTIVE： To provide reference for improving China’s national medicine policy framework. METHODS： The medicine policy documents of 2009-April 2019 were collected， and then policy texts were categorized according to national medicine policy elements of WHO. According to the number and strength of policies， the construction of national medicine policy framework was analyzed. The main reform measures of different themes were extracted and summarized. On this basis， the logic of medicine reform in China was analyzed. RESULTS & CONCLUSIONS： National medicine policy framework has been established primarily， but it is not balanced， such as the number and intensity of policies on human resources and medicine financing are slightly inadequate. Analysis of China’s national medicine policy framework reveals that： （1） in the process of construction， “quality assurance” and “affordability” are the two main policy lines， and “quality improvement” and “cost reduction” are the two main policy objectives； （2） the construction of national medicine policy framework has a phased reform focus， and it has gone through a process from “demand-side reform” to “supply-side and demand-side reform”； （3） the importance of medicine procurement in the reform has been strengthened continuously. It is suggested to strengthen the balance of national medicine policy， improve human resources， medicine financing and rational medicine use policy construction； it is also suggested to strengthen top-level design， establish a multi-department collaborative decision-making and coordination mechanism， and enhance the coordination of medicine policies； in addition， the role of procurement links reform should be further played .
ABSTRACT
Por meio de um levantamento bibliográfico sobre as políticas públicas no setor de medicamentos brasileiro, o artigo examina as principais características das ações aplicadas na área, ressaltando seus resultados e deficiências, bem como as dificuldades encontradas para consolidar uma política de medicamentos no Brasil. O estudo realizado se fundamentou na análise de artigos por meio das bases de dados Scielo e Lilacs e de outras fontes. Desde a extinta Central de Medicamentos (CEME) até a aprovação da Política Nacional de Medicamentos (PNM), todas as ações e projetos foram voltados principalmente para a reorientação da Assistência Farmacêutica na atenção básica, garantindo, por conseguinte, o acesso e o uso racional dos medicamentos essenciais.
Through a bibliography review of public policies in Brazilian medicine sector, this paper examines the main characteristics of actions implemented in this area, lighting their results and deficiencies, as well as the difficulties to consolidate a policy for medicines in Brazil. The study is based on analysis of articles searched in the Scielo and Lilacs databases and other sources. Since the extinct Medicine Center to the approval of the National Medicine Policy, all the actions and programs aimed mainly at the reorientation of Pharmaceutical Assistance in primary health are, to guarantee access and rational use of essential medicines essential.
Subject(s)
Humans , Drugs, Essential , National Drug Policy , Pharmaceutical ServicesABSTRACT
OBJECTIVE:To explore the establishment of performance indicator system for evaluating national essential drug system in China.METHODS:Reference to the field of health policy performance evaluation research and practice at home and abroad.WHO indicators for evaluating national drug policies,and a qualitative study on the theory and approach of policy evaluation was conducted.RESULTS & CONCLUSION:To establish a China-specific performance evaluation indicator system,policy goals should be specified,and evaluation criterions and policy components should be also defined firstly.An indicator system framework of national essential drug system which based on WHO recommendatory indicators should be proposed accordingly.But detailed indicators should be established based on field research and experts counseling.